WhatiLearned.com
WhatiLearned.com - What I Learned

Caspase-2 enzyme inhibitor shows promise for ameliorating fatty liver disease

26



Researchers have discovered using mice and human clinical specimens that caspase-2, a protein-cleaving enzyme, is a critical driver of non-alcoholic steatohepatitis (NASH), a chronic and aggressive liver condition. By identifying caspase-2’s critical role, they believe an inhibitor of this enzyme could provide an effective way to stop the pathogenic progression that leads to NASH — and possibly even reverse early symptoms.

See the World for Less!

Source

Comments
Loading...
%d bloggers like this: